ArticleFrontiers in oncology2025

Postoperative adjuvant hepatic arterial infusion chemotherapy with gemcitabine-cisplatin sequential capecitabine combined with PDL1 inhibitors in resected high-risk intrahepatic cholangiocarcinom: study protocol for a prospective, multicenter, single-arm, phase 2 trial (HgcCP trial).

Ying Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.